We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Advances in Cancer Therapy from Research to Clinical Practice—Surgical, Molecular or Systemic Management of Cancer.
- Authors
Cainap, Calin; Crisan, Nicolae
- Abstract
As shown by Szep et al. [[8]], multiparametric breast MRI (magnetic resonance imaging), which provides morphological and functional images of breast tumours, is nowadays a part of the recommended workup for breast cancer. The molecular types can change the MRI aspect of breast cancer, whereas MRI can be used to predict the molecular types (but not replace the biopsy). Inflammation in cancer could be a target for immunomodulatory treatment, but could also represent an unfavourable factor for patients, being responsible for cancer progression. Moreover, Mkrantonakis et al. [[6]] tried to identify triple-negative breast cancer (TNBC) patients who have a better or worse response to immunomodulator agents, which are newcomers in the breast cancer armamentarium.
- Subjects
MEDICAL research; LOBULAR carcinoma; MEDICAL personnel; CANCER treatment; TRIPLE-negative breast cancer; BLOOD diseases
- Publication
Medicina (1010660X), 2023, Vol 59, Issue 7, p1309
- ISSN
1010-660X
- Publication type
Article
- DOI
10.3390/medicina59071309